These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35323873)

  • 1. Towards a New Qualitative Screening Assay for Synthetic Cannabinoids Using Metabolomics and Machine Learning.
    Streun GL; Steuer AE; Poetzsch SN; Ebert LC; Dobay A; Kraemer T
    Clin Chem; 2022 Jun; 68(6):848-855. PubMed ID: 35323873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretable machine learning model to detect chemically adulterated urine samples analyzed by high resolution mass spectrometry.
    Streun GL; Steuer AE; Ebert LC; Dobay A; Kraemer T
    Clin Chem Lab Med; 2021 Jul; 59(8):1392-1399. PubMed ID: 33742969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time-of-flight mass spectrometry after solid phase extraction.
    Kleis JN; Hess C; Germerott T; Roehrich J
    Drug Test Anal; 2021 Aug; 13(8):1535-1551. PubMed ID: 33884774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable Data Independent Acquisition and Data Mining Exploring Feature-Based Molecular Networking Analysis for Untargeted Screening of Synthetic Cannabinoids in Oral Fluid.
    de Albuquerque Cavalcanti G; Moreira Borges R; Reis Alves Carneiro G; Costa Padilha M; Gualberto Pereira HM
    J Am Soc Mass Spectrom; 2021 Sep; 32(9):2417-2424. PubMed ID: 34399051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the retention time of Synthetic Cannabinoids using a combinatorial QSAR approach.
    Wu L; Xiao F; Luo X; Yun K; Wen D; Lin J; Yang S; Li T; Xiang P; Shi Y
    Heliyon; 2023 Jun; 9(6):e16671. PubMed ID: 37484220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples.
    Janssens LK; Boeckaerts D; Hudson S; Morozova D; Cannaert A; Wood DM; Wolfe C; De Baets B; Stock M; Dargan PI; Stove CP
    Clin Chem; 2022 Jul; 68(7):906-916. PubMed ID: 35266984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What about the herb? A new metabolomics approach for synthetic cannabinoid drug testing.
    Bijlsma L; Gil-Solsona R; Hernández F; Sancho JV
    Anal Bioanal Chem; 2018 Aug; 410(21):5107-5112. PubMed ID: 29909458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous screening of 239 synthetic cannabinoids and metabolites in blood and urine samples using liquid chromatography-high resolution mass spectrometry.
    Shi Y; Liu M; Li X; Xu N; Yuan S; Yu Z; Xiang P; Wu H
    J Chromatogr A; 2022 Jan; 1663():462743. PubMed ID: 34974369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
    Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
    Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study on early postmortem submersion interval (PMSI) estimation and cause-of-death discrimination based on nontargeted metabolomics and machine learning algorithms.
    Zhang FY; Wang LL; Dong WW; Zhang M; Tash D; Li XJ; Du SK; Yuan HM; Zhao R; Guan DW
    Int J Legal Med; 2022 May; 136(3):941-954. PubMed ID: 35099605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined metabolomics and machine learning algorithms to explore metabolic biomarkers for diagnosis of acute myocardial ischemia.
    Cao J; Li J; Gu Z; Niu JJ; An GS; Jin QQ; Wang YY; Huang P; Sun JH
    Int J Legal Med; 2023 Jan; 137(1):169-180. PubMed ID: 35348878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of lemon juice adulteration by targeted screening using LC-UV-MS and untargeted screening using UHPLC-QTOF/MS with machine learning.
    Lyu W; Yuan B; Liu S; Simon JE; Wu Q
    Food Chem; 2022 Mar; 373(Pt A):131424. PubMed ID: 34710685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
    Yeter O; Erol Öztürk Y
    Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization.
    Huppertz LM; Kneisel S; Auwärter V; Kempf J
    J Mass Spectrom; 2014 Feb; 49(2):117-27. PubMed ID: 24677304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of XCMS Optimization Methods with Machine-Learning Performance.
    Lassen J; Nielsen KL; Johannsen M; Villesen P
    Anal Chem; 2021 Oct; 93(40):13459-13466. PubMed ID: 34585906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MetaClean: a machine learning-based classifier for reduced false positive peak detection in untargeted LC-MS metabolomics data.
    Chetnik K; Petrick L; Pandey G
    Metabolomics; 2020 Oct; 16(11):117. PubMed ID: 33085002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of synthetic cannabinoid 5F-ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra-high-performance liquid chromatography/high-resolution mass spectrometry.
    Presley BC; Castaneto MS; Logan BK; Jansen-Varnum SA
    Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8908. PubMed ID: 32710798
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.